Healthcare -
Biotechnology - NASDAQ - US
$ 2.45
6.52 %
$ 170 M
Market Cap
-0.79
P/E
IKT - OPERATING INCOME
Operating Income IKT - Inhibikase Therapeutics, Inc.
-20.1 M
LAST VALUE
-16.64%
2 YEAR CAGR
-56.76%
5 YEAR CAGR
0.00%
10 YEAR CAGR